MarketScreener Editorial Features Alnylam Pharmaceuticals, Inc.
Stocks
ALNY
US02043Q1076
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 287.92 USD | -3.63% |
|
-8.05% | -27.61% |
| 07-09 | Raymond James Adjusts Price Target on Alnylam Pharmaceuticals to $468 From $420, Maintains Outperform Rating | MT |
| 07-09 | AstraZeneca's Wainua fails key heart disease trial, shares tumble | RE |
MarketScreener Editorial Features
Search
No results match your criteria
- Stock Market
- Stocks
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- MarketScreener Editorial Features
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition